Neethi Dasu
Atrial fibrillation is a common disorder which can potentially have multiple adverse outcomes. One such outcome is the development of ischemic bowel disease. The aims of this study are: to evaluate the role of CHA2DS2-VASc score as a predictor of higher mortality in patients who have atrial fibrillation and ischemic bowel disease, i.e. if a higher CHA2DS2-VASc score is associated with higher mortality; to evaluate whether being on anticoagulation is associated with a lower mortality for such patients in this population.
PDFShare this article